Feedback / Questions
Jemperli (dostarlimab-gxly) - GSK
belrestotug (EOS-448) - iTeos, GSK
https://medicaldialogues.in/news/industry/pharma/gsk-pharma-india-gets-cdsco-panel-nod-for-phase-3-ct-of-belrestotug-and-dostarlimab-132247
Jul 26, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next